on 08 Jan 2020
Last Applicant/ Owned by
ELI LILLY AND COMPANY
Lilly Corporate CenterIndianapolis, IN 46285
US
Serial Number
1864838 filed on 26th Oct 2017
Registration Number
TMA1068523 registered on 08th Jan 2020
Registration expiry Date
08th Jan 2030Correspondent Address
World Exchange Plaza100 Queen Street, Suite 1300Ottawa
ONTARIO
CA
K1P1J9
EMGALITY AND DESIGN
Vienna Information
25 . 7 . 1
Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés
25 . 7 . 7
Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points
25 . 7 . 6
Surfaces or backgrounds covered with circles or ellipsesSurfaces ou fonds couverts de cercles ou d'ellipses
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 13
Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie
26 . 11 . 14
Dotted lines or bandsLignes ou bandes pointillées
Trademark usage description
pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read MoreClassification Information
Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Classification kind code
11
Class [044]
Medical information services in the field of central nervous systems diseases and disorders
Classification kind code
11
Mark Details
Serial Number
1864838
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 190 on 31st Jul 2019 | Registration Pending |
| Submitted for opposition 191 on 31st Jul 2019 | Registration Fee Notice Sent |
| Submitted for opposition 42 on 08th May 2019 | Advertised |
| Submitted for opposition 26 on 18th Apr 2019 | Approved |
| Submitted for opposition 27 on 01st Mar 2019 | Approval Notice Sent |
| Submitted for opposition 22 on 03rd Jan 2019 | Search Recorded |
| Submitted for opposition 20 on 03rd Jan 2019 | Examiner's First Report |
| Submitted for opposition 1 on 27th Oct 2017 | Created |
| Submitted for opposition 31 on 27th Oct 2017 | Formalized |
| Submitted for opposition 30 on 26th Oct 2017 | Filed |